(1)
Alzheimer’s Dementia: Budget Impact and Cost-Utility Analysis of a Combination Treatment With a cholinesterase Inhibitor and Memantine in Switzerland. Swiss Med Wkly 2012, 142 (4748), w13676. https://doi.org/10.4414/smw.2012.13676.